You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Norwegian company Navamedic, a specialty pharmaceutical company, has acquired the Swedish medtech company Observe Medical. The initial purchase price is NOK 35 million, with additional payments dependent on performance in the coming years. Observe Medical has developed an automated, digital uAlready a subscriber Login You have read all your…
The company has been granted an Advanced Therapy Medicinal Product (ATMP) certificate following a review of manufacturing quality and non-clinical data for its lead pipeline program vididencel by the European Medicines Agency (EMA). Although this certification is not a requirement for a future apAlready a subscriber Login You have read…
AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has accepted the first Biologics License Application (BLA) for durvalumab, a PD-L1 human monoclonal antibody (mAb), and granted priority review status with a PrescriAlready a subscriber Login You have read all…
The two companies announce that the European Commission has granted a marketing authorization for Ximluci (ranibizumab), a biosimilar candidate referencing Lucentis. This follows the positive opinion issued by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Already a subscriber Login You have read all your free articles,…
